Pectus Excavatum Camouflage

NAActive, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Pectus Excavatum
Interventions
DEVICE

PCL Pectus Scaffold implantation and autologous fat grafting

A small incision is made in the chest and pre-sternal pocked is defined. Following this, an empty scaffold is implanted at the site of the defect with skin closed directly over it. At the same stage, autologous fat transfer will be performed, harvesting fat from available donor sites such as the thighs and abdomen - depending on scaffold volume and patient morphology. The area will be infiltrated with local anaesthetic tumescent fluid, liposuction performed, and fat transferred to syringes for filtration prior to injection into the scaffold. Fat will not be processed beyond simple filtration to separate liquid from fat to be injected. The scaffold provides structural stability to the chest during the infiltration of the tissue inside the scaffold.

Trial Locations (1)

4102

Princess Alexandra Hospital - Wooloongabba, Brisbane

All Listed Sponsors
lead

BellaSeno Pty Ltd

INDUSTRY

NCT05451108 - Pectus Excavatum Camouflage | Biotech Hunter | Biotech Hunter